A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

This study has been completed.
Information provided by (Responsible Party):
Centocor, Inc.
ClinicalTrials.gov Identifier:
First received: November 4, 2008
Last updated: April 9, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: December 18, 2012